Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 16, 2017

Primary Completion Date

May 16, 2024

Study Completion Date

May 16, 2024

Conditions
Pulmonary Arterial Hypertension
Interventions
PROCEDURE

Cardiac magnetic resonance imaging (cMRI)

"Right ventricular contouring and indexed aortic flow measurement from cMRI will be performed locally with the dedicated software used in clinical practice by the physicians of each centre. Cardiac index and RVEF will be derived from these measures. MRI interpretation will be performed blind with respect of clinical and RHC data.~A self-administered questionnaire made up of 2 Likert scales will be given to all patients on visits V1, V2 or V3 and V9.~To constitute a biobank for diagnosis and prognosis purposes blood samples will be taken at visits V1, V2 or V3 and V9."

Trial Locations (1)

54511

RECRUITING

Professor Ari CHAOUAT, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER